ACTRIMS 2024
Multiple Sclerosis News Today is providing coverage of the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 Feb. 29-March 2 in West Palm Beach, Florida. The theme of this year’s conference is “Breaking Barriers in MS.”
People with relapsing forms of multiple sclerosis (MS) being treated with an infusion CD20 inhibitor such as Ocrevus (ocrelizumab) can safely transition to the more recent Briumvi (ublituximab-xiiy), which is given in shorter infusion times. That’s according to data from the ENHANCE Phase 3b clinical trial…
Recommended Posts
- Common anti-aging drugs may damage brain’s protective coating
- My MS diagnosis opened a window to a whole new world
- Close relatives of MS patients face 100 times higher risk of developing disorder
- Coping with MS means sometimes being inattentive to myself and others
- UC Davis Health named Center for Comprehensive MS Care